看看查看全文
来源:格隆汇 格隆汇6月14日丨Agile Therapeutics(AGRX.US)盘前涨35.65%,报4.87美元。Agile Therapeutics宣布与VitaCare处方服务公司达成新协议,以扩大Twirla的使用范围,推动公司2023年实现净收入2500万至30... 网页链接
$Agile Therapeutics(AGRX)$ 8-K - Current report Filed: 2016-11-07 AccNo: 0001104659-16-155186 Size: 142 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Agile Therapeutics(AGRX)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-11-07 AccNo: 0001104659-16-155190 Size: 3 MB 网页链接
$Agile Therapeutics(AGRX)$ 8-K - Current report Filed: 2016-11-07 AccNo: 0001104659-16-155186 Size: 142 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Agile Therapeutics(AGRX)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2016-10-27 AccNo: 0000950142-16-004646 Size: 187 KB 网页链接
$Agile Therapeutics(AGRX)$ 美东时间 2016-11-07 16:30 After Market Close:AGILE THERAP Earning Release . Wall St EPS Est ($):-0.35. 网页链接
$Agile Therapeutics(AGRX)$ 8-K - Current report Filed: 2016-10-06 AccNo: 0001104659-16-149129 Size: 20 KBItem 8.01: Other Events 网页链接
$Agile Therapeutics(AGRX)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2016-10-03 AccNo: 0000950142-16-004532 Size: 193 KB 网页链接
$Agile Therapeutics(AGRX)$ 8-K - Current report Filed: 2016-08-26 AccNo: 0001104659-16-141659 Size: 86 KBItem 1.01: Entry into a Material Definitive AgreementItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Regi...
$Agile Therapeutics(AGRX)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-08-08 AccNo: 0001104659-16-137918 Size: 3 MB 网页链接
$Agile Therapeutics(AGRX)$ 8-K - Current report Filed: 2016-08-08 AccNo: 0001104659-16-137910 Size: 139 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接